我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 宇宙IF
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Changing Trends of Liver Diseases in Benin City, A Twenty (1985-2004) Years Comparative Histopathology Study

Nnadi IG1* and Obaseki DE2

Aim: The aim of this study is to determine the pattern chronic liver diseases histologically diagnosed in the
University of Benin Teaching Hospital between 1985and 2004 and compare with previous study of histopathological
diseases of the liver in a previous study.
Methodology: The surgical daybooks, histopathology request and report forms were the sources of data used for
this study. All liver biopsies received at the Department of Pathology, University of Benin Teaching Hospital, Benin City,
Edo State, Nigeria, from January 1985 to December 2004were reviewed.
Results: A total of 235 liver biopsies were received in the Department of Histopathology, University of Benin
Teaching Hospital, Benin City during the period under review. The commonest hepatic disease was viral hepatitis 78
cases (33.19%). Followed byhepatocellular carcinoma 59 cases (25.10%), 33 cases (14.04%) of cirrhosis, 26 cases of
metastatic tumors to the liver (11.06%), five cases (2.13%) of primary biliary cirrhosis, four cases (1.70%) of alcoholic
liver disease, three cases (1.28%) of neonatal hepatitis, hepatoblastoma, fatty change and Non-Hodgkin lymphoma
respectively; two cases (0.85%) of cholangiocarcinoma, haemangioendothelioma, sarcoidosis, and neonatal giant cell
hepatitis respectively and one case (0.43%) each of glycogen storage disorder, extrahepatic biliary atresia, fulminant
hepatitis, hepatic abscess, congenital hepatic fibrosis, polycystic hepatic disease, cavernous haemangioma and
hepatic cholestasis.
Conclusion: The predominant liver diseases were inflammatory diseases(50.22%), malignant neoplasm(40.42%),
biliary tract disorders (2.99%) and metabolic disorders (2.56%).